GGrantIndex
Sort

78,016 grants matching breast cancer

Effects of genetic polymorphism in MHC, KIR, and related loci on human disease

$981,463
Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Clinical development of mechanism-based lymphoma therapies

$981,462
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Molecular Imaging and Theranostics of Cancer

$981,390
Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2018 · CA

Expansion Research Capability to Study Comparative Effectiveness in Complex Pati*

$981,252
Youjie Huang · Florida State Department Of Health · R24 · FY2010 · HS

Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes

$981,204
Lawrence H Kushi · Kaiser Foundation Research Institute · R01 · FY2020 · CA

Nanotechnology for Multiplexed and Intraoperative Cancer Detection

$980,999
Shuming Nie · Emory University · RC2 · FY2009 · CA

Molecular Pathology Research for Cancer Diagnostics and Biomarkers

$980,906
Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

Targeting Multiple Diseases Through Gamma Secretase

$980,825
Barbara A Osborne · University Of Massachusetts Amherst · P01 · FY2013 · CA

PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm

$980,392
John Gillespie · 20/20 Genesystems, Inc. · R44 · FY2012 · CA

Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data

$980,257
Martin Akerman · Envisagenics, Inc. · R44 · FY2023 · CA

Missouri Valley Cancer Consortium CCOP

$980,000
Missouri Valley Cancer Consortium, Inc. · U10 · FY2002 · CA

Molecular, Cellular, and Tissue Characterization Unit

$979,965
William E Gillanders · Washington University · U2C · FY2022 · CA

Molecular Analysis of Breast Cancer Metastasis to the Brain

$979,883
Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

SIOUX COMMUNITY CANCER CONSORTIUM

$979,880
Sanford Research/Usd · U10 · FY2002 · CA

TempO-Seq for Preserved Tissues in Toxicity Testing Phase II

$979,864
Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2017 · ES

Molecular Epidemiology Studies of Occupational and Environmental Exposures

$979,771
Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA

Nuclear Factor-kappaB in Ovarian Cancer

$979,598
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Immunology of aging and immunotherapy of aging-associated diseases

$979,308
Arya Biragyn · National Institute On Aging · ZIA · FY2023 · AG

MammoCAT Advanced Full Field Digital Mammography System

$979,261
Shabbir Bakir Bambot · Fischer Imaging, Inc. · R44 · FY2023 · CA

Texas Center for Minority Health, Education, Research and Outreach

$979,101
Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · U54 · FY2019 · MD

Optimizing Radiosynthetic Yield of [18F]FTT For Wide-Spread Distribution

$979,093
Michel Mikhail · Trevarx Biomedical, Inc. · R42 · FY2024 · CA

Automated Systems for Detection and Molecular Characterization of Circulating Tum

$979,021
Yuling Luo · Advanced Cell Diagnostics, Inc. · R44 · FY2012 · CA

Prospective Studies of Diet and Cancer in the AARP Cohort

$978,928
Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.

$978,693
Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · U01 · FY2023 · CA

Scaling Social Determinants of Health Screening, Social Support and Anti-Racism Training to Reduce Inequities in Minority Cancer Survivor Health and Wellbeing in Washington, DC

$978,463
Hannah Arem · Medstar Health Research Institute · U01 · FY2021 · DP